title: Biotech firms pin hopes on defence.
authors.forename: Helen
authors.initials: H
authors.lastname: Pearson
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000818:Animals; D000881:Anthrax / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D000907:Antibodies, Bacterial / Q000627:therapeutic use; D001709:Biotechnology / Q000191:economics* / Q000639:trends*; D023482:Bioterrorism / Q000517:prevention & control*; D014481:United States; D014612:Vaccines / Q000191:economics / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D014612:Vaccines